These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7375814)

  • 1. Procarbazine-induced skin reactions in Hodgkin's disease and other malignant lymphomas.
    Andersen E; Videbaek A
    Scand J Haematol; 1980 Feb; 24(2):149-51. PubMed ID: 7375814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersensitivity to procarbazine associated with angioedema, urticaria, and low serum complement activity.
    Glovsky MM; Braunwald J; Opelz G; Alenty A
    J Allergy Clin Immunol; 1976 Feb; 57(2):134-40. PubMed ID: 1249347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of advanced malignant lymphomas comparative evaluation of results with single agent and combination therapy.
    Klener P; Donner L; Roth Z
    Neoplasma; 1976; 23(3):315-22. PubMed ID: 958533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
    Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
    Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity to procarbazine (Matulane) manifested by fever and pleuropulmonary reaction.
    Jones SE; Moore M; Blank N; Castellino RA
    Cancer; 1972 Feb; 29(2):498-500. PubMed ID: 5013552
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
    Klein HO
    Hamatol Bluttransfus; 1976; 18():135-45. PubMed ID: 786808
    [No Abstract]   [Full Text] [Related]  

  • 7. Delayed life-threatening pneumonitis secondary to procarbazine.
    Brooks BJ; Hendler NB; Alvarez S; Ancalmo N; Grinton SF
    Am J Clin Oncol; 1990 Jun; 13(3):244-6. PubMed ID: 2346130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Allergic reaction to the administration of natulan in a patient with Hodgkin's disease].
    Pavlov VV; Isaev IG
    Probl Gematol Pereliv Krovi; 1978 May; 23(5):52-3. PubMed ID: 149972
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
    Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
    J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse pulmonary disease after therapy with nitrogen mustard, vincristine, procarbazine, and prednisone.
    Farney RJ; Morris AH; Armstrong JD; Hammer S
    Am Rev Respir Dis; 1977 Jan; 115(1):135-45. PubMed ID: 835882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Hodgkin's disease and other malignant lymphomas.
    Aungst CW
    J Surg Oncol; 1973 Jun; 5(6):575-9. PubMed ID: 4589653
    [No Abstract]   [Full Text] [Related]  

  • 12. [CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)].
    Sampi K; Honda T; Hattori M
    Rinsho Ketsueki; 1984 Feb; 25(2):164-8. PubMed ID: 6547984
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy of malignant lymphomas.
    Bonadonna G
    Semin Oncol; 1985 Dec; 12(4 Suppl 6):1-14. PubMed ID: 2417334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation.
    Br Med J; 1975 Aug; 3(5980):413-4. PubMed ID: 1098721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Hodgkin's and non-Hodgkin's lymphomas.
    Sahakian GJ
    Med Clin North Am; 1975 Mar; 59(2):387-97. PubMed ID: 1117771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results.
    Hancock BW; Vaughan Hudson G; Vaughan Hudson B; Haybittle JL; Bennett MH; MacLennan KA; Jelliffe AM
    Br J Cancer; 1991 Apr; 63(4):579-82. PubMed ID: 2021542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease.
    Huguley CM; Durant JR; Moores RR; Chan YK; Dorfman RF; Johnson L
    Cancer; 1975 Oct; 36(4):1227-40. PubMed ID: 1175125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new combination chemotherapy for recurrent Hodgkin's lymphoma.
    Rahim MA; Sarma SK; Ahmed Q
    Bangladesh Med Res Counc Bull; 1982 Dec; 8(2):63-7. PubMed ID: 6897860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment.
    Swerdlow AJ; Schoemaker MJ; Allerton R; Horwich A; Barber JA; Cunningham D; Lister TA; Rohatiner AZ; Vaughan Hudson G; Williams MV; Linch DC
    J Clin Oncol; 2001 Mar; 19(6):1610-8. PubMed ID: 11250989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.